OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

MODERNA INC. DL-,0001/  US60770K1079  /

München
2024-04-18  4:55:38 PM Chg. -1.41 Volume Bid9:59:58 PM Ask9:59:58 PM Market Capitalization Dividend Y. P/E Ratio
96.57EUR -1.44% 3
Turnover: 289.71		 -Bid Size: - -Ask Size: - 36.62 bill.EUR - -
TeleTrader 04-09 US markets close mostly higher ahead of inflation report
GlobeNewswire 04-04 Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
TeleTrader 03-28 US closes mixed amid data
TeleTrader 03-26 Wall Street closes lower after economic data
GlobeNewswire 03-21 Immatics Announces Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 03-11 CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
GlobeNewswire 03-04 CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
GlobeNewswire 02-29 Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire 02-27 CytomX Therapeutics to Present at Upcoming March Investor Conferences
TeleTrader 02-23 Asia-Pacific mostly up on US markets gains
TeleTrader 02-22 Nasdaq closes with 3% boost led by Nvidia rally
TeleTrader 02-22 Wall Street extends rally, Dow soars 500 pts
TeleTrader 02-22 Moderna rallies 13% after earnings
TeleTrader 02-22 Moderna's Q4 revenue down 81% to $2.8 billion
TeleTrader 02-22 US higher premarket with earnings in focus
TeleTrader 02-19 Earnings preview: Nvidia leads the pack this week
TeleTrader 02-18 Weekly Preview: All eyes on economy and earnings
TeleTrader 01-16 US opens lower after earnings
GlobeNewswire 01-12 CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference
GlobeNewswire 01-09 PRISM MarketView Honors National Biotechnology Month with a Spotlight on Emerging Biotech Innovators
TeleTrader 01-08 Moderna expects $4B in product sales in 2024
GlobeNewswire 01-08 Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
GlobeNewswire 01-04 CytomX Therapeutics Outlines 2024 Company Priorities and Milestones
TeleTrader 2023-12-27 US closes higher in anticipation of 2024
GlobeNewswire 2023-12-21 CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference